These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 20361743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9.
    Yu D, Wang D, Zhu FG, Bhagat L, Dai M, Kandimalla ER, Agrawal S.
    J Med Chem; 2009 Aug 27; 52(16):5108-14. PubMed ID: 19650625
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
    Jurk M, Kritzler A, Debelak H, Vollmer J, Krieg AM, Uhlmann E.
    ChemMedChem; 2006 Sep 27; 1(9):1007-14. PubMed ID: 16952134
    [Abstract] [Full Text] [Related]

  • 9. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 10. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 10; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 11. Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.
    Wang D, Bhagat L, Yu D, Zhu FG, Tang JX, Kandimalla ER, Agrawal S.
    J Med Chem; 2009 Jan 22; 52(2):551-8. PubMed ID: 19102653
    [Abstract] [Full Text] [Related]

  • 12. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM, Merrell MA, Li L, Wakchoure S, Graves D, Brooks S, Rahko E, Jukkola-Vuorinen A, Vuopala KS, Harris KW, Selander KS.
    Mol Cancer Res; 2008 Oct 22; 6(10):1534-43. PubMed ID: 18922969
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and immunological activities of novel agonists of toll-like receptor 9.
    Struthers M, Bett AJ, Wisniewski T, Dubey SA, Precopio M, Jiang W, Sun Z, Wang H, Nowak I, Putta MR, Yu D, Tang JX, Kandimalla ER, Agrawal S, Casimiro DR.
    Cell Immunol; 2010 Oct 22; 263(1):105-13. PubMed ID: 20381019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthetic agonists of Toll-like receptors 7, 8 and 9.
    Agrawal S, Kandimalla ER.
    Biochem Soc Trans; 2007 Dec 22; 35(Pt 6):1461-7. PubMed ID: 18031246
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
    Schetter C, Vollmer J.
    Curr Opin Drug Discov Devel; 2004 Mar 22; 7(2):204-10. PubMed ID: 15603254
    [Abstract] [Full Text] [Related]

  • 19. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N, Fan XG, Tang SE, Zhu C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct 22; 30(5):533-5. PubMed ID: 16320582
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13.
    Nurmenniemi S, Kuvaja P, Lehtonen S, Tiuraniemi S, Alahuhta I, Mattila RK, Risteli J, Salo T, Selander KS, Nyberg P, Lehenkari P.
    Exp Cell Res; 2010 Oct 01; 316(16):2676-82. PubMed ID: 20553713
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.